nrf1 Search Results


95
Cell Signaling Technology Inc antibody targeting nrf1 tcf11
Antibody Targeting Nrf1 Tcf11, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf1/TCF11%2FNRF1+Rabbit+mAb/pmc12574707-368-7-11
Average 95 stars, based on 1 article reviews
antibody targeting nrf1 tcf11 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc nrf1 d9k6p
a RT–QPCR analysis of the mRNA expression of <t>NRF1</t> and mtTFA in lineage −/low cells after treated with IMP for 24 h, n = 6. b – e Western blot analysis expression level of NRF1, mtTFA and PFAS in IMP-treated cells for 24 or 72 h compared with controls, n = 15–27. Data are presented as the means ± SEM. f – h ADSS, ATPase and IMPDH2 activity in lineage −/low cells which were stimulated with IMP for 0, 4, and 8 h, n = 6. i ATP and GTP production in lineage −/low cells after 24 and 72 h of IMP treatment, n = 6. j , k Oxygen consumption rate analysis of the Lineage −/low cells which were exposed to PBS or 15 mM IMP for 6 h, n = 6. One-way ANOVA with Dunnett was used to compare groups against control. IMP Inosine-5′-monophosphate, ADSS adenylosuccinate synthetase, IMPDH2 Inosine-5′-monophosphate dehydrogenase 2, ATP Adenosine triphosphate, GTP guanosine triphosphate, NRF1 nuclear respiratory factor 1, PFAS phosphoribosylformylglycinamidine synthase.
Nrf1 D9k6p, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf1/NRF1+Rabbit+mAb/pmc09556615-340-44-50
Average 95 stars, based on 1 article reviews
nrf1 d9k6p - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

95
Proteintech nrf1
Antibodies
Nrf1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf1/NRF1%2Fnuclear+respiratory+factor+1+Polyclonal+antibody/pmc10731721-17-0-4
Average 95 stars, based on 1 article reviews
nrf1 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology nrf1 shrna
a The chromatin binding sites and enrichment of 33 responsive OCTFs generated through a motif enrichment analysis of MCF-7- and ADR-biased COGC-seq peaks are shown in a heat map. The color of the dots represents the TF motif enrichment. More TF-binding sites are indicated by a large dot size. b Average enrichment profiles of <t>NRF1</t> ChIP-seq reads (MCF-7 and ADR cells) and published HCF-1 ChIP-seq reads (MCF-7, GSE91992 ) at differential quantitative COGC-seq peaks. c COGC-seq peaks in MCF-7 and ADR cells overlap with NRF1 and a published HCF-1 ( GSE91992 ) ChIP-seq dataset. d O-GlcNAc NRF1 was upregulated in MCF-7 cells after transient stimulation with 100 nM Adm. IP of NRF1 was performed, and the immunoprecipitated fractions were analyzed by immunoblotting for O-GlcNAc (CTD110.6). e The NRF1-HCF-1 interaction is increased in ADR cells compared with MCF-7 cells. NRF1 co-IP was performed, and the immunoprecipitated fractions were analyzed by immunoblotting for the indicated proteins. f NRF-1 is O-GlcNAcylated at Ser448/Ser451. After treatment with PugNAc (Pug, 100 μM) and glucose (Glu, 25 mM) for 24 h, MCF-7 cells stably expressing Flag-WT-NRF1 or Flag-AA-NRF1 were immunoprecipitated with anti-Flag magnetic beads. O-GlcNAcylation (CTD110.6) was analyzed by immunoblotting. WT, wild-type NRF1; AA, Ser447/Ser450 → Ala mutational NRF1. Mock, cells transfected with empty pCMVPuro64 vector. g O-GlcNAc promotes the interaction of HCF-1 and OGT with NRF1. Immunoblotting showing the PPIs of endogenous HCF-1 and OGT with NRF1 in ADR cells. ADR cells stably expressing Flag-WT-NRF1 or Flag-AA-NRF1 were immunoprecipitated with anti-Flag magnetic beads. h O-GlcNAc inhibition expedites the degradation of NRF1. ADR cells expressing Flag-WT-NRF1 or Flag-AA-NRF1 were incubated with 50 μM cycloheximide (CHX) for up to 12 h. The expression levels of Flag-NRF1 were monitored by immunoblotting. i O-GlcNAc enhances the chromatin binding of NRF1. The crosslinked chromatin proteins were extracted, and the levels of Flag-NRF1 were detected by immunoblotting. For ( d – i ), all blots are representative of at least two biologically independent experiments. a , d – i Source Data are provided as a Source Data file.
Nrf1 Shrna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf1/Nrf1+shRNA+Plasmid/pmc07678849-321-6-16
Average 91 stars, based on 1 article reviews
nrf1 shrna - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

93
Rockland Immunochemicals anti nrf 1
a The chromatin binding sites and enrichment of 33 responsive OCTFs generated through a motif enrichment analysis of MCF-7- and ADR-biased COGC-seq peaks are shown in a heat map. The color of the dots represents the TF motif enrichment. More TF-binding sites are indicated by a large dot size. b Average enrichment profiles of <t>NRF1</t> ChIP-seq reads (MCF-7 and ADR cells) and published HCF-1 ChIP-seq reads (MCF-7, GSE91992 ) at differential quantitative COGC-seq peaks. c COGC-seq peaks in MCF-7 and ADR cells overlap with NRF1 and a published HCF-1 ( GSE91992 ) ChIP-seq dataset. d O-GlcNAc NRF1 was upregulated in MCF-7 cells after transient stimulation with 100 nM Adm. IP of NRF1 was performed, and the immunoprecipitated fractions were analyzed by immunoblotting for O-GlcNAc (CTD110.6). e The NRF1-HCF-1 interaction is increased in ADR cells compared with MCF-7 cells. NRF1 co-IP was performed, and the immunoprecipitated fractions were analyzed by immunoblotting for the indicated proteins. f NRF-1 is O-GlcNAcylated at Ser448/Ser451. After treatment with PugNAc (Pug, 100 μM) and glucose (Glu, 25 mM) for 24 h, MCF-7 cells stably expressing Flag-WT-NRF1 or Flag-AA-NRF1 were immunoprecipitated with anti-Flag magnetic beads. O-GlcNAcylation (CTD110.6) was analyzed by immunoblotting. WT, wild-type NRF1; AA, Ser447/Ser450 → Ala mutational NRF1. Mock, cells transfected with empty pCMVPuro64 vector. g O-GlcNAc promotes the interaction of HCF-1 and OGT with NRF1. Immunoblotting showing the PPIs of endogenous HCF-1 and OGT with NRF1 in ADR cells. ADR cells stably expressing Flag-WT-NRF1 or Flag-AA-NRF1 were immunoprecipitated with anti-Flag magnetic beads. h O-GlcNAc inhibition expedites the degradation of NRF1. ADR cells expressing Flag-WT-NRF1 or Flag-AA-NRF1 were incubated with 50 μM cycloheximide (CHX) for up to 12 h. The expression levels of Flag-NRF1 were monitored by immunoblotting. i O-GlcNAc enhances the chromatin binding of NRF1. The crosslinked chromatin proteins were extracted, and the levels of Flag-NRF1 were detected by immunoblotting. For ( d – i ), all blots are representative of at least two biologically independent experiments. a , d – i Source Data are provided as a Source Data file.
Anti Nrf 1, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf1/NRF1+ANTIBODY/pmc04430710-47-70-71
Average 93 stars, based on 1 article reviews
anti nrf 1 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology nrf1
Figure 1. Effects of LP programming on the expression of genes involved in mitochondrial dynamics and biogenesis in the skeletal muscle of control and LP rats. The mRNA levels of mitochondrial dynamic genes: (a) Mfn1; (b) Mfn2; (c) Opa1; (d) Fis1; (e) Drp1 (f) Tfam, (g) Pgc1A (h) Pgc1B (i) Essra (j) <t>Nrf1</t> were analyzed by qPCR. The mRNA expressions of each gene were normalized to the average of internal controls. Data represent mean ± SEM (* p < 0.05, ** p < 0.01); n = 5.
Nrf1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf1/Nrf1+Antibody/10__3390_slash_ijms252312860-417-23-60
Average 95 stars, based on 1 article reviews
nrf1 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc nrf1
Figure 1. Effects of LP programming on the expression of genes involved in mitochondrial dynamics and biogenesis in the skeletal muscle of control and LP rats. The mRNA levels of mitochondrial dynamic genes: (a) Mfn1; (b) Mfn2; (c) Opa1; (d) Fis1; (e) Drp1 (f) Tfam, (g) Pgc1A (h) Pgc1B (i) Essra (j) <t>Nrf1</t> were analyzed by qPCR. The mRNA expressions of each gene were normalized to the average of internal controls. Data represent mean ± SEM (* p < 0.05, ** p < 0.01); n = 5.
Nrf1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf1/NRF1+Rabbit+mAb/pm36960492-50-16-23
Average 94 stars, based on 1 article reviews
nrf1 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology nrf 1 sirna
Figure 1. Effects of LP programming on the expression of genes involved in mitochondrial dynamics and biogenesis in the skeletal muscle of control and LP rats. The mRNA levels of mitochondrial dynamic genes: (a) Mfn1; (b) Mfn2; (c) Opa1; (d) Fis1; (e) Drp1 (f) Tfam, (g) Pgc1A (h) Pgc1B (i) Essra (j) <t>Nrf1</t> were analyzed by qPCR. The mRNA expressions of each gene were normalized to the average of internal controls. Data represent mean ± SEM (* p < 0.05, ** p < 0.01); n = 5.
Nrf 1 Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf1/Nrf1+siRNA/pmc02785686-260-3-14
Average 91 stars, based on 1 article reviews
nrf 1 sirna - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

94
ABclonal Biotechnology sirt1
Figure 14. <t>SIRT1</t> expression in TM3 cells and testicular interstitial tissue. (A) Western blotting analysis of SIRT1 expression in TM3 cells treated with different durations of MT. (B) Relative expression analysis of SIRT1 protein following varying durations of MT treatment (N = 3). a Compared to the control group, p < 0.05; b Compared to the 1 h MT treatment group, p < 0.05; c Compared to the 3 h MT treatment group, p < 0.05; d Compared to the 6 h MT treatment group, p < 0.05. (C) Western blotting analysis of SIRT1 expression in TM3 cells across different treatment groups. (D) Relative
Sirt1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf1/NRF1+Rabbit+mAb/pm40565373-304-35-37
Average 94 stars, based on 1 article reviews
sirt1 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology antibodies against nrf1
Fig. 1 <t>NRF1</t> is highly upregulated in HCC and correlated with poor prognosis of patients with HCC. A GSEA was applied to compare NRF1 activity in HCC and normal tissue in TCGA-LIHC dataset. B-C NRF1 mRNA level was compared between tumors and normal tissue (B) or paired tumors and adjacent normal tissue (C) in TCGA-LIHC dataset. D-E The correlation of NRF1 mRNA level and TNM stage (D) or pathological grade (E) in TCGA-LIHC dataset. F NRF1 expression in our HCC tissue and adjacent normal tissue was determined by Western blot. G-H The representative IHC images of NRF1 was exhibited (G) and the IHC score (n = 65) was shown (H). Scale bar: 50 μm. I-J NRF1 mRNA and protein levels in HCC cell lines and normal liver cell line were analysed by qRT-PCR (I) and Western blot (J). K-L Kaplan–meier curve showed the effect of NRF1 on HCC overall survival (K) and disease free survival (L) in TCGA-LIHC dataset. M Forest plot showed Cox proportional hazards model for disease free survival in TCGA-LIHC dataset. N The relevance of NRF1 expression and HCC patients survival was analyzed with GSEA in TCGA-LIHC dataset. *p < 0.05, **p < 0.01, ***p < 0.001
Antibodies Against Nrf1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf1/NRF1+Rabbit+pAb/pm37875967-84-13-19
Average 94 stars, based on 1 article reviews
antibodies against nrf1 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

85
Addgene inc e2f2 nrf 1
Fig. 1 <t>NRF1</t> is highly upregulated in HCC and correlated with poor prognosis of patients with HCC. A GSEA was applied to compare NRF1 activity in HCC and normal tissue in TCGA-LIHC dataset. B-C NRF1 mRNA level was compared between tumors and normal tissue (B) or paired tumors and adjacent normal tissue (C) in TCGA-LIHC dataset. D-E The correlation of NRF1 mRNA level and TNM stage (D) or pathological grade (E) in TCGA-LIHC dataset. F NRF1 expression in our HCC tissue and adjacent normal tissue was determined by Western blot. G-H The representative IHC images of NRF1 was exhibited (G) and the IHC score (n = 65) was shown (H). Scale bar: 50 μm. I-J NRF1 mRNA and protein levels in HCC cell lines and normal liver cell line were analysed by qRT-PCR (I) and Western blot (J). K-L Kaplan–meier curve showed the effect of NRF1 on HCC overall survival (K) and disease free survival (L) in TCGA-LIHC dataset. M Forest plot showed Cox proportional hazards model for disease free survival in TCGA-LIHC dataset. N The relevance of NRF1 expression and HCC patients survival was analyzed with GSEA in TCGA-LIHC dataset. *p < 0.05, **p < 0.01, ***p < 0.001
E2f2 Nrf 1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf1/161%2B80pCalb2%2FE2F2%2FNRF-1(-64)-like+(Plasmid+%2366742)/pmc05008284-171-31-33
Average 85 stars, based on 1 article reviews
e2f2 nrf 1 - by Bioz Stars, 2026-10
85/100 stars
  Buy from Supplier

Image Search Results


a RT–QPCR analysis of the mRNA expression of NRF1 and mtTFA in lineage −/low cells after treated with IMP for 24 h, n = 6. b – e Western blot analysis expression level of NRF1, mtTFA and PFAS in IMP-treated cells for 24 or 72 h compared with controls, n = 15–27. Data are presented as the means ± SEM. f – h ADSS, ATPase and IMPDH2 activity in lineage −/low cells which were stimulated with IMP for 0, 4, and 8 h, n = 6. i ATP and GTP production in lineage −/low cells after 24 and 72 h of IMP treatment, n = 6. j , k Oxygen consumption rate analysis of the Lineage −/low cells which were exposed to PBS or 15 mM IMP for 6 h, n = 6. One-way ANOVA with Dunnett was used to compare groups against control. IMP Inosine-5′-monophosphate, ADSS adenylosuccinate synthetase, IMPDH2 Inosine-5′-monophosphate dehydrogenase 2, ATP Adenosine triphosphate, GTP guanosine triphosphate, NRF1 nuclear respiratory factor 1, PFAS phosphoribosylformylglycinamidine synthase.

Journal: Communications Biology

Article Title: The purine metabolite inosine monophosphate accelerates myelopoiesis and acute pancreatitis progression

doi: 10.1038/s42003-022-04041-0

Figure Lengend Snippet: a RT–QPCR analysis of the mRNA expression of NRF1 and mtTFA in lineage −/low cells after treated with IMP for 24 h, n = 6. b – e Western blot analysis expression level of NRF1, mtTFA and PFAS in IMP-treated cells for 24 or 72 h compared with controls, n = 15–27. Data are presented as the means ± SEM. f – h ADSS, ATPase and IMPDH2 activity in lineage −/low cells which were stimulated with IMP for 0, 4, and 8 h, n = 6. i ATP and GTP production in lineage −/low cells after 24 and 72 h of IMP treatment, n = 6. j , k Oxygen consumption rate analysis of the Lineage −/low cells which were exposed to PBS or 15 mM IMP for 6 h, n = 6. One-way ANOVA with Dunnett was used to compare groups against control. IMP Inosine-5′-monophosphate, ADSS adenylosuccinate synthetase, IMPDH2 Inosine-5′-monophosphate dehydrogenase 2, ATP Adenosine triphosphate, GTP guanosine triphosphate, NRF1 nuclear respiratory factor 1, PFAS phosphoribosylformylglycinamidine synthase.

Article Snippet: Primary antibodies used in our experiments were as follows: Akt (cat. 9272, diluted 1:1000, CST, Danvers, MA, USA); phospho-Akt (Ser473) (D9E) (cat. 4060, diluted 1:1000, CST); S6 Ribosomal Protein (54D2) (cat. 2317, diluted 1:1000, CST); phospho-S6 Ribosomal Protein (Ser235/236) (cat. 2211, diluted 1:1000, CST); NRF1 (D9K6P) (cat. 46743, diluted 1:1000, CST); mtTFA (cat. ab272885, diluted 1:1000, Abcam, Cambridge, UK); PGC-1α (cat. 66369-1-Ig, diluted 1:1000, Proteintech, Chicago, IL, USA); β-actin (13E5) (cat. 4970, diluted 1:2000, CST).

Techniques: Quantitative RT-PCR, Expressing, Western Blot, Activity Assay, Control

Antibodies

Journal: Journal of Translational Medicine

Article Title: Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis

doi: 10.1186/s12967-023-04790-4

Figure Lengend Snippet: Antibodies

Article Snippet: NRF1 , Rabbit , Proteintech , 12482-1-AP , 1:1000.

Techniques:

Didymin enhances mitochondrial biogenesis and function by activating Sirt1 in PA-treated AML12 cells. A MitoTracker Green staining for mitochondrial content in AML12 cells. (n = 3, Scale bar = 20 μm). B Mitochondrial oxygen consumption ratio (OCR) of AML12 cells (n = 4). C ROS concentration in AML12 cells (n = 4). D Immunoprecipitation of PGC-1α in AML12 cells showing acetylated PGC-1α level (n = 3). E Western blot analysis of NRF1, TFAM, NDUFB8, SDHB, and MTCO2 in AML12 cells (n = 3). Data are expressed as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001 PA vs. PA + Didymin. # P < 0.05, ## P < 0.01, ### P < 0.001, #### P < 0.0001 control vs. PA. PA palmitic acid, PGC-1α proliferative activated receptor γ coactivator 1α, NRF1 nuclear respiratory factor 1, TFAM mitochondrial transcription factor A

Journal: Journal of Translational Medicine

Article Title: Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis

doi: 10.1186/s12967-023-04790-4

Figure Lengend Snippet: Didymin enhances mitochondrial biogenesis and function by activating Sirt1 in PA-treated AML12 cells. A MitoTracker Green staining for mitochondrial content in AML12 cells. (n = 3, Scale bar = 20 μm). B Mitochondrial oxygen consumption ratio (OCR) of AML12 cells (n = 4). C ROS concentration in AML12 cells (n = 4). D Immunoprecipitation of PGC-1α in AML12 cells showing acetylated PGC-1α level (n = 3). E Western blot analysis of NRF1, TFAM, NDUFB8, SDHB, and MTCO2 in AML12 cells (n = 3). Data are expressed as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001 PA vs. PA + Didymin. # P < 0.05, ## P < 0.01, ### P < 0.001, #### P < 0.0001 control vs. PA. PA palmitic acid, PGC-1α proliferative activated receptor γ coactivator 1α, NRF1 nuclear respiratory factor 1, TFAM mitochondrial transcription factor A

Article Snippet: NRF1 , Rabbit , Proteintech , 12482-1-AP , 1:1000.

Techniques: Staining, Concentration Assay, Immunoprecipitation, Western Blot, Control

Didymin enhances mitochondrial biogenesis and function, promotes lipophagy, and inhibits apoptosis by activating Sirt1 in mice hepatocytes. A Western blot analysis of Sirt1 expression in hepatocytes (n = 3). B Western blot analysis of NRF1, TFAM, NDUFB8, SDHB, and MTCO2 in hepatocytes. C Transmission electron microscopy figures of hepatocytes, arrows show mitochondria (Scale bar = 0.6 μm). D Transmission electron microscopy figures of hepatocytes, arrows show autolysosomes (Scale bar = 0.6 μm). E Western blot analysis of LC3, Beclin1, P62, PLIN2, LAMP1, and ATG5 in hepatocytes (n = 3). F Western blot analysis of Cleaved PARP, Bax, Bcl2, Cleaved Caspase 3, and Caspase 3 proteins in hepatocytes (n = 3). G Immunofluorescence staining of γ-H2AX in hepatocytes (Scale bar = 50 μm). NRF1 nuclear respiratory factor 1, TFAM mitochondrial transcription factor A, PLIN2 perilipin 2, LAMP1 lysosomal associated membrane protein 1, Bax Bcl-2-associated X protein, Bcl2 B-cell lymphoma 2

Journal: Journal of Translational Medicine

Article Title: Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis

doi: 10.1186/s12967-023-04790-4

Figure Lengend Snippet: Didymin enhances mitochondrial biogenesis and function, promotes lipophagy, and inhibits apoptosis by activating Sirt1 in mice hepatocytes. A Western blot analysis of Sirt1 expression in hepatocytes (n = 3). B Western blot analysis of NRF1, TFAM, NDUFB8, SDHB, and MTCO2 in hepatocytes. C Transmission electron microscopy figures of hepatocytes, arrows show mitochondria (Scale bar = 0.6 μm). D Transmission electron microscopy figures of hepatocytes, arrows show autolysosomes (Scale bar = 0.6 μm). E Western blot analysis of LC3, Beclin1, P62, PLIN2, LAMP1, and ATG5 in hepatocytes (n = 3). F Western blot analysis of Cleaved PARP, Bax, Bcl2, Cleaved Caspase 3, and Caspase 3 proteins in hepatocytes (n = 3). G Immunofluorescence staining of γ-H2AX in hepatocytes (Scale bar = 50 μm). NRF1 nuclear respiratory factor 1, TFAM mitochondrial transcription factor A, PLIN2 perilipin 2, LAMP1 lysosomal associated membrane protein 1, Bax Bcl-2-associated X protein, Bcl2 B-cell lymphoma 2

Article Snippet: NRF1 , Rabbit , Proteintech , 12482-1-AP , 1:1000.

Techniques: Western Blot, Expressing, Transmission Assay, Electron Microscopy, Immunofluorescence, Staining, Membrane

Schematic representation of Didymin alleviates MAFLD through the Sirt1 pathway. Didymin binds to SIRT1 protein and activates its deacetylase activity, which in turn deacetylates FoxO3a and PGC-1α and enhances their activity. FoxO3a further increases the expression level of SIRT1 and promotes the process of lipophagy. The increase in lipophagy activity can further inhibit cell apoptosis. PGC-1α enhances mitochondrial biosynthesis and improves mitochondrial function by promoting the transcription of NRF1 and TFAM. PGC-1α proliferative activated receptor γ coactivator 1α, NRF1 nuclear respiratory factor 1, TFAM mitochondrial transcription factor A, FoxO3a Foxkhead Box Class O 3a, PLIN2 perilipin 2, LAMP1 lysosomal associated membrane protein 1, Bax Bcl-2-associated X protein, Bcl2 B-cell lymphoma 2

Journal: Journal of Translational Medicine

Article Title: Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis

doi: 10.1186/s12967-023-04790-4

Figure Lengend Snippet: Schematic representation of Didymin alleviates MAFLD through the Sirt1 pathway. Didymin binds to SIRT1 protein and activates its deacetylase activity, which in turn deacetylates FoxO3a and PGC-1α and enhances their activity. FoxO3a further increases the expression level of SIRT1 and promotes the process of lipophagy. The increase in lipophagy activity can further inhibit cell apoptosis. PGC-1α enhances mitochondrial biosynthesis and improves mitochondrial function by promoting the transcription of NRF1 and TFAM. PGC-1α proliferative activated receptor γ coactivator 1α, NRF1 nuclear respiratory factor 1, TFAM mitochondrial transcription factor A, FoxO3a Foxkhead Box Class O 3a, PLIN2 perilipin 2, LAMP1 lysosomal associated membrane protein 1, Bax Bcl-2-associated X protein, Bcl2 B-cell lymphoma 2

Article Snippet: NRF1 , Rabbit , Proteintech , 12482-1-AP , 1:1000.

Techniques: Histone Deacetylase Assay, Activity Assay, Expressing, Membrane

a The chromatin binding sites and enrichment of 33 responsive OCTFs generated through a motif enrichment analysis of MCF-7- and ADR-biased COGC-seq peaks are shown in a heat map. The color of the dots represents the TF motif enrichment. More TF-binding sites are indicated by a large dot size. b Average enrichment profiles of NRF1 ChIP-seq reads (MCF-7 and ADR cells) and published HCF-1 ChIP-seq reads (MCF-7, GSE91992 ) at differential quantitative COGC-seq peaks. c COGC-seq peaks in MCF-7 and ADR cells overlap with NRF1 and a published HCF-1 ( GSE91992 ) ChIP-seq dataset. d O-GlcNAc NRF1 was upregulated in MCF-7 cells after transient stimulation with 100 nM Adm. IP of NRF1 was performed, and the immunoprecipitated fractions were analyzed by immunoblotting for O-GlcNAc (CTD110.6). e The NRF1-HCF-1 interaction is increased in ADR cells compared with MCF-7 cells. NRF1 co-IP was performed, and the immunoprecipitated fractions were analyzed by immunoblotting for the indicated proteins. f NRF-1 is O-GlcNAcylated at Ser448/Ser451. After treatment with PugNAc (Pug, 100 μM) and glucose (Glu, 25 mM) for 24 h, MCF-7 cells stably expressing Flag-WT-NRF1 or Flag-AA-NRF1 were immunoprecipitated with anti-Flag magnetic beads. O-GlcNAcylation (CTD110.6) was analyzed by immunoblotting. WT, wild-type NRF1; AA, Ser447/Ser450 → Ala mutational NRF1. Mock, cells transfected with empty pCMVPuro64 vector. g O-GlcNAc promotes the interaction of HCF-1 and OGT with NRF1. Immunoblotting showing the PPIs of endogenous HCF-1 and OGT with NRF1 in ADR cells. ADR cells stably expressing Flag-WT-NRF1 or Flag-AA-NRF1 were immunoprecipitated with anti-Flag magnetic beads. h O-GlcNAc inhibition expedites the degradation of NRF1. ADR cells expressing Flag-WT-NRF1 or Flag-AA-NRF1 were incubated with 50 μM cycloheximide (CHX) for up to 12 h. The expression levels of Flag-NRF1 were monitored by immunoblotting. i O-GlcNAc enhances the chromatin binding of NRF1. The crosslinked chromatin proteins were extracted, and the levels of Flag-NRF1 were detected by immunoblotting. For ( d – i ), all blots are representative of at least two biologically independent experiments. a , d – i Source Data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Proteomic profiling and genome-wide mapping of O-GlcNAc chromatin-associated proteins reveal an O-GlcNAc-regulated genotoxic stress response

doi: 10.1038/s41467-020-19579-y

Figure Lengend Snippet: a The chromatin binding sites and enrichment of 33 responsive OCTFs generated through a motif enrichment analysis of MCF-7- and ADR-biased COGC-seq peaks are shown in a heat map. The color of the dots represents the TF motif enrichment. More TF-binding sites are indicated by a large dot size. b Average enrichment profiles of NRF1 ChIP-seq reads (MCF-7 and ADR cells) and published HCF-1 ChIP-seq reads (MCF-7, GSE91992 ) at differential quantitative COGC-seq peaks. c COGC-seq peaks in MCF-7 and ADR cells overlap with NRF1 and a published HCF-1 ( GSE91992 ) ChIP-seq dataset. d O-GlcNAc NRF1 was upregulated in MCF-7 cells after transient stimulation with 100 nM Adm. IP of NRF1 was performed, and the immunoprecipitated fractions were analyzed by immunoblotting for O-GlcNAc (CTD110.6). e The NRF1-HCF-1 interaction is increased in ADR cells compared with MCF-7 cells. NRF1 co-IP was performed, and the immunoprecipitated fractions were analyzed by immunoblotting for the indicated proteins. f NRF-1 is O-GlcNAcylated at Ser448/Ser451. After treatment with PugNAc (Pug, 100 μM) and glucose (Glu, 25 mM) for 24 h, MCF-7 cells stably expressing Flag-WT-NRF1 or Flag-AA-NRF1 were immunoprecipitated with anti-Flag magnetic beads. O-GlcNAcylation (CTD110.6) was analyzed by immunoblotting. WT, wild-type NRF1; AA, Ser447/Ser450 → Ala mutational NRF1. Mock, cells transfected with empty pCMVPuro64 vector. g O-GlcNAc promotes the interaction of HCF-1 and OGT with NRF1. Immunoblotting showing the PPIs of endogenous HCF-1 and OGT with NRF1 in ADR cells. ADR cells stably expressing Flag-WT-NRF1 or Flag-AA-NRF1 were immunoprecipitated with anti-Flag magnetic beads. h O-GlcNAc inhibition expedites the degradation of NRF1. ADR cells expressing Flag-WT-NRF1 or Flag-AA-NRF1 were incubated with 50 μM cycloheximide (CHX) for up to 12 h. The expression levels of Flag-NRF1 were monitored by immunoblotting. i O-GlcNAc enhances the chromatin binding of NRF1. The crosslinked chromatin proteins were extracted, and the levels of Flag-NRF1 were detected by immunoblotting. For ( d – i ), all blots are representative of at least two biologically independent experiments. a , d – i Source Data are provided as a Source Data file.

Article Snippet: SP1 siRNA (#sc-29487), KLF5 siRNA (#sc-37718), NRF1 shRNA (#sc-38105-SH) and NSMCE2 siRNA (#sc-77813) were purchased from Santa Cruz Biotechnology.

Techniques: Binding Assay, Generated, ChIP-sequencing, Immunoprecipitation, Western Blot, Co-Immunoprecipitation Assay, Stable Transfection, Expressing, Magnetic Beads, Transfection, Plasmid Preparation, Inhibition, Incubation

a NRF-1 ChIP-seq signal in NRF-1 uniquely bound sites identified by overlapping MCF-7 and ADR NRF-1 peaks. Upper panel: Venn diagram showing the overlap of NRF-1 peaks in MCF-7 and ADR cells. The percentage of peaks annotated to promoter regions is indicated. Lower panel: Heat map representation of NRF-1 signal enrichment (red, low; blue, high) at NRF-1 uniquely bound sites. The enrichment levels were profiled ±3 kb from the peak center. b Heat map representation of COGC-seq signal enrichment (red, low; blue, high) at NRF-1 uniquely bound sites. The enrichment levels were profiled ±3 kb from the peak center. c Average enrichment profiles of published H3K27ac, H3K4me3 ( GSE97481 ), H3K27me3 ( GSE96363 ) and H3K4me1 ( GSE86714 ) ChIP-seq reads at NRF-1 uniquely bound sites. d The box plots showing the mRNA expression changes (RNA-seq FPKM) of NRF1-binding genes associated with MCF-7- and ADR-biased peaks. The box plots show the medians (black lines), 25th and 75th percentiles (boundaries), and minimum/maximum values (whiskers). The p value (0.0000006, two-sided unpaired Student’s t -test, calculated between multiple genes in each group) is indicated. n = 2 biologically independent RNA-seq replicates. Source Data are provided as a Source Data file. e Heat map representation of WT-NRF-1 and AA-NRF-1 signal enrichment (red, low; blue, high) at NRF-1 binding sites in MCF-7 and ADR cells. The enrichment levels were profiled ±3 kb from the peak center.

Journal: Nature Communications

Article Title: Proteomic profiling and genome-wide mapping of O-GlcNAc chromatin-associated proteins reveal an O-GlcNAc-regulated genotoxic stress response

doi: 10.1038/s41467-020-19579-y

Figure Lengend Snippet: a NRF-1 ChIP-seq signal in NRF-1 uniquely bound sites identified by overlapping MCF-7 and ADR NRF-1 peaks. Upper panel: Venn diagram showing the overlap of NRF-1 peaks in MCF-7 and ADR cells. The percentage of peaks annotated to promoter regions is indicated. Lower panel: Heat map representation of NRF-1 signal enrichment (red, low; blue, high) at NRF-1 uniquely bound sites. The enrichment levels were profiled ±3 kb from the peak center. b Heat map representation of COGC-seq signal enrichment (red, low; blue, high) at NRF-1 uniquely bound sites. The enrichment levels were profiled ±3 kb from the peak center. c Average enrichment profiles of published H3K27ac, H3K4me3 ( GSE97481 ), H3K27me3 ( GSE96363 ) and H3K4me1 ( GSE86714 ) ChIP-seq reads at NRF-1 uniquely bound sites. d The box plots showing the mRNA expression changes (RNA-seq FPKM) of NRF1-binding genes associated with MCF-7- and ADR-biased peaks. The box plots show the medians (black lines), 25th and 75th percentiles (boundaries), and minimum/maximum values (whiskers). The p value (0.0000006, two-sided unpaired Student’s t -test, calculated between multiple genes in each group) is indicated. n = 2 biologically independent RNA-seq replicates. Source Data are provided as a Source Data file. e Heat map representation of WT-NRF-1 and AA-NRF-1 signal enrichment (red, low; blue, high) at NRF-1 binding sites in MCF-7 and ADR cells. The enrichment levels were profiled ±3 kb from the peak center.

Article Snippet: SP1 siRNA (#sc-29487), KLF5 siRNA (#sc-37718), NRF1 shRNA (#sc-38105-SH) and NSMCE2 siRNA (#sc-77813) were purchased from Santa Cruz Biotechnology.

Techniques: ChIP-sequencing, Expressing, RNA Sequencing, Binding Assay

a Effect of NRF1 O-GlcNAc modification on the indicated gene transcription levels in ADR cells. The gene mRNA levels in ADR cells expressing Flag-WT-NRF1 or Flag-AA-NRF1 were analyzed by quantitative PCR (qPCR). b Left panel: IGV tracks showing the signals at the promoter regions of the representative genes. Right panel: Validation of O-GlcNAc NRF1 binding peaks by ChIP-qPCR. qPCR amplification was performed. Each bar represents the fold enrichment of binding relative to the input. IgG and random primers that could not specifically bind the indicated gene promoter regions (off target) were used as negative controls. Mock, cells transfected with empty pCMVPuro64 vector. c O-GlcNAc inhibition reduces the transcriptional activity of NRF1. 293T cells were transfected with a reporter vector consisting of luciferase cDNA fused to the NSMCE2 promoter. The pGL3-basic vector (Mock) was used as a control. d ADR cells were transfected with NSMCE2 siRNA (siNSMCE2) or scrambled siRNA (siScr) and treated with increasing doses of Adm for 48 h. The cell viability was then assessed. Representative images of cell viability determined by crystal violet staining are shown. Results were reproduced in two biologically independent experiments. The protein levels of NSMCE2 were monitored by immunoblotting. All blots are representative of at least two biologically independent experiments. For ( a - c ), the data are presented as the means ± SEM., ( d ) replicates are represented. ( a – d ) n = 3 biologically independent experiments, * p < 0.05, ** p < 0.01, *** p < 0.001 (two-sided unpaired Student’s t -test). p values: 0.010099, 0.001375, 0.046814, 0.020148 ( a ); 0.010191, 0.000117, 0.000159, 0.001032 ( b ); 0.0065 (WT-NRF1 vs. WT-NRF1 L01), 0.0002 (WT-NRF1 vs. AA-NRF1), 0.0000858 (WT-NRF1 vs. AA-NRF1 L01) ( c ); 0.001575 ( d ). a – d Experiments were repeated independently two times with similar results. Source Data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Proteomic profiling and genome-wide mapping of O-GlcNAc chromatin-associated proteins reveal an O-GlcNAc-regulated genotoxic stress response

doi: 10.1038/s41467-020-19579-y

Figure Lengend Snippet: a Effect of NRF1 O-GlcNAc modification on the indicated gene transcription levels in ADR cells. The gene mRNA levels in ADR cells expressing Flag-WT-NRF1 or Flag-AA-NRF1 were analyzed by quantitative PCR (qPCR). b Left panel: IGV tracks showing the signals at the promoter regions of the representative genes. Right panel: Validation of O-GlcNAc NRF1 binding peaks by ChIP-qPCR. qPCR amplification was performed. Each bar represents the fold enrichment of binding relative to the input. IgG and random primers that could not specifically bind the indicated gene promoter regions (off target) were used as negative controls. Mock, cells transfected with empty pCMVPuro64 vector. c O-GlcNAc inhibition reduces the transcriptional activity of NRF1. 293T cells were transfected with a reporter vector consisting of luciferase cDNA fused to the NSMCE2 promoter. The pGL3-basic vector (Mock) was used as a control. d ADR cells were transfected with NSMCE2 siRNA (siNSMCE2) or scrambled siRNA (siScr) and treated with increasing doses of Adm for 48 h. The cell viability was then assessed. Representative images of cell viability determined by crystal violet staining are shown. Results were reproduced in two biologically independent experiments. The protein levels of NSMCE2 were monitored by immunoblotting. All blots are representative of at least two biologically independent experiments. For ( a - c ), the data are presented as the means ± SEM., ( d ) replicates are represented. ( a – d ) n = 3 biologically independent experiments, * p < 0.05, ** p < 0.01, *** p < 0.001 (two-sided unpaired Student’s t -test). p values: 0.010099, 0.001375, 0.046814, 0.020148 ( a ); 0.010191, 0.000117, 0.000159, 0.001032 ( b ); 0.0065 (WT-NRF1 vs. WT-NRF1 L01), 0.0002 (WT-NRF1 vs. AA-NRF1), 0.0000858 (WT-NRF1 vs. AA-NRF1 L01) ( c ); 0.001575 ( d ). a – d Experiments were repeated independently two times with similar results. Source Data are provided as a Source Data file.

Article Snippet: SP1 siRNA (#sc-29487), KLF5 siRNA (#sc-37718), NRF1 shRNA (#sc-38105-SH) and NSMCE2 siRNA (#sc-77813) were purchased from Santa Cruz Biotechnology.

Techniques: Modification, Expressing, Real-time Polymerase Chain Reaction, Biomarker Discovery, Binding Assay, ChIP-qPCR, Amplification, Transfection, Plasmid Preparation, Inhibition, Activity Assay, Luciferase, Control, Staining, Western Blot

Genotoxicity provokes O-GlcNAc (G) elevation and dynamic changes in multiple OCTF genomic binding sites. The activity of multiple OCTFs, including NRF1, modulates a network of transcriptome upregulation to induce a holistic effect on cell fates in response to genotoxic stress.

Journal: Nature Communications

Article Title: Proteomic profiling and genome-wide mapping of O-GlcNAc chromatin-associated proteins reveal an O-GlcNAc-regulated genotoxic stress response

doi: 10.1038/s41467-020-19579-y

Figure Lengend Snippet: Genotoxicity provokes O-GlcNAc (G) elevation and dynamic changes in multiple OCTF genomic binding sites. The activity of multiple OCTFs, including NRF1, modulates a network of transcriptome upregulation to induce a holistic effect on cell fates in response to genotoxic stress.

Article Snippet: SP1 siRNA (#sc-29487), KLF5 siRNA (#sc-37718), NRF1 shRNA (#sc-38105-SH) and NSMCE2 siRNA (#sc-77813) were purchased from Santa Cruz Biotechnology.

Techniques: Binding Assay, Activity Assay

Figure 1. Effects of LP programming on the expression of genes involved in mitochondrial dynamics and biogenesis in the skeletal muscle of control and LP rats. The mRNA levels of mitochondrial dynamic genes: (a) Mfn1; (b) Mfn2; (c) Opa1; (d) Fis1; (e) Drp1 (f) Tfam, (g) Pgc1A (h) Pgc1B (i) Essra (j) Nrf1 were analyzed by qPCR. The mRNA expressions of each gene were normalized to the average of internal controls. Data represent mean ± SEM (* p < 0.05, ** p < 0.01); n = 5.

Journal: International Journal of Molecular Sciences

Article Title: Maternal Low-Protein Diet Leads to Mitochondrial Dysfunction and Impaired Energy Metabolism in the Skeletal Muscle of Male Rats

doi: 10.3390/ijms252312860

Figure Lengend Snippet: Figure 1. Effects of LP programming on the expression of genes involved in mitochondrial dynamics and biogenesis in the skeletal muscle of control and LP rats. The mRNA levels of mitochondrial dynamic genes: (a) Mfn1; (b) Mfn2; (c) Opa1; (d) Fis1; (e) Drp1 (f) Tfam, (g) Pgc1A (h) Pgc1B (i) Essra (j) Nrf1 were analyzed by qPCR. The mRNA expressions of each gene were normalized to the average of internal controls. Data represent mean ± SEM (* p < 0.05, ** p < 0.01); n = 5.

Article Snippet: Details of primary antibodies and their dilutions are as follows: and Gapdh (Cat #97166, 1:1000), Vdac1 (Cat #4661, 1:1000), Opa1 (Cat #80471, 1:1000), Nrf1 (Cat #46743, 1:1000), Sirt1 (Cat #9475, 1:1000), Erra (Cat #13826, 1:1000), Cox-IV (Cat #4850, 1:5000) were obtained from cell signaling, Danvers, MA, USA; Fis1 (Cat # sc-376447, 1:1000), Mfn2 (Cat # sc-515647, 1:1000) were obtained from Santa Cruz Biotechnology, Dallas, TX, USA.

Techniques: Expressing, Control

Figure 14. SIRT1 expression in TM3 cells and testicular interstitial tissue. (A) Western blotting analysis of SIRT1 expression in TM3 cells treated with different durations of MT. (B) Relative expression analysis of SIRT1 protein following varying durations of MT treatment (N = 3). a Compared to the control group, p < 0.05; b Compared to the 1 h MT treatment group, p < 0.05; c Compared to the 3 h MT treatment group, p < 0.05; d Compared to the 6 h MT treatment group, p < 0.05. (C) Western blotting analysis of SIRT1 expression in TM3 cells across different treatment groups. (D) Relative

Journal: International journal of molecular sciences

Article Title: Melatonin Alleviates MBP-Induced Oxidative Stress and Apoptosis in TM3 Cells via the SIRT1/PGC-1α Signaling Pathway.

doi: 10.3390/ijms26125910

Figure Lengend Snippet: Figure 14. SIRT1 expression in TM3 cells and testicular interstitial tissue. (A) Western blotting analysis of SIRT1 expression in TM3 cells treated with different durations of MT. (B) Relative expression analysis of SIRT1 protein following varying durations of MT treatment (N = 3). a Compared to the control group, p < 0.05; b Compared to the 1 h MT treatment group, p < 0.05; c Compared to the 3 h MT treatment group, p < 0.05; d Compared to the 6 h MT treatment group, p < 0.05. (C) Western blotting analysis of SIRT1 expression in TM3 cells across different treatment groups. (D) Relative

Article Snippet: The membrane was then blocked with 5% non-fat milk for 1 h and incubated overnight at 4 ◦C with primary antibodies: PGC-1α (1:1000; ABclonal, Wuhan, China; #A20995), NRF2 (1:1000, ABclonal, #A25327), NRF1 (1:1000, ABclonal, #A3252), SIRT1 (1:1000, ABclonal, #A0230), Bcl-2 (1:300, BIOSS, Beijing, China; #bs-4563R), cleaved-caspase3 (1:1000, #A27145, ABclonal), Bax (1:1000, BIOSS, #bs-0127R), and β-actin (1:100,000, ABclonal, #AC026).

Techniques: Expressing, Western Blot, Control

Figure 15. Expression of SIRT1 and PGC-1α in TM3 cells. (A) Western blotting analysis of SIRT1 expression in TM3 cells across different treatment groups. (B) Relative expression analysis of SIRT1

Journal: International journal of molecular sciences

Article Title: Melatonin Alleviates MBP-Induced Oxidative Stress and Apoptosis in TM3 Cells via the SIRT1/PGC-1α Signaling Pathway.

doi: 10.3390/ijms26125910

Figure Lengend Snippet: Figure 15. Expression of SIRT1 and PGC-1α in TM3 cells. (A) Western blotting analysis of SIRT1 expression in TM3 cells across different treatment groups. (B) Relative expression analysis of SIRT1

Article Snippet: The membrane was then blocked with 5% non-fat milk for 1 h and incubated overnight at 4 ◦C with primary antibodies: PGC-1α (1:1000; ABclonal, Wuhan, China; #A20995), NRF2 (1:1000, ABclonal, #A25327), NRF1 (1:1000, ABclonal, #A3252), SIRT1 (1:1000, ABclonal, #A0230), Bcl-2 (1:300, BIOSS, Beijing, China; #bs-4563R), cleaved-caspase3 (1:1000, #A27145, ABclonal), Bax (1:1000, BIOSS, #bs-0127R), and β-actin (1:100,000, ABclonal, #AC026).

Techniques: Expressing, Western Blot

Fig. 1 NRF1 is highly upregulated in HCC and correlated with poor prognosis of patients with HCC. A GSEA was applied to compare NRF1 activity in HCC and normal tissue in TCGA-LIHC dataset. B-C NRF1 mRNA level was compared between tumors and normal tissue (B) or paired tumors and adjacent normal tissue (C) in TCGA-LIHC dataset. D-E The correlation of NRF1 mRNA level and TNM stage (D) or pathological grade (E) in TCGA-LIHC dataset. F NRF1 expression in our HCC tissue and adjacent normal tissue was determined by Western blot. G-H The representative IHC images of NRF1 was exhibited (G) and the IHC score (n = 65) was shown (H). Scale bar: 50 μm. I-J NRF1 mRNA and protein levels in HCC cell lines and normal liver cell line were analysed by qRT-PCR (I) and Western blot (J). K-L Kaplan–meier curve showed the effect of NRF1 on HCC overall survival (K) and disease free survival (L) in TCGA-LIHC dataset. M Forest plot showed Cox proportional hazards model for disease free survival in TCGA-LIHC dataset. N The relevance of NRF1 expression and HCC patients survival was analyzed with GSEA in TCGA-LIHC dataset. *p < 0.05, **p < 0.01, ***p < 0.001

Journal: Biology direct

Article Title: Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1/2-CREB axis.

doi: 10.1186/s13062-023-00428-z

Figure Lengend Snippet: Fig. 1 NRF1 is highly upregulated in HCC and correlated with poor prognosis of patients with HCC. A GSEA was applied to compare NRF1 activity in HCC and normal tissue in TCGA-LIHC dataset. B-C NRF1 mRNA level was compared between tumors and normal tissue (B) or paired tumors and adjacent normal tissue (C) in TCGA-LIHC dataset. D-E The correlation of NRF1 mRNA level and TNM stage (D) or pathological grade (E) in TCGA-LIHC dataset. F NRF1 expression in our HCC tissue and adjacent normal tissue was determined by Western blot. G-H The representative IHC images of NRF1 was exhibited (G) and the IHC score (n = 65) was shown (H). Scale bar: 50 μm. I-J NRF1 mRNA and protein levels in HCC cell lines and normal liver cell line were analysed by qRT-PCR (I) and Western blot (J). K-L Kaplan–meier curve showed the effect of NRF1 on HCC overall survival (K) and disease free survival (L) in TCGA-LIHC dataset. M Forest plot showed Cox proportional hazards model for disease free survival in TCGA-LIHC dataset. N The relevance of NRF1 expression and HCC patients survival was analyzed with GSEA in TCGA-LIHC dataset. *p < 0.05, **p < 0.01, ***p < 0.001

Article Snippet: After being blocked by skim milk, PVDF membranes were incubated with corresponding primary antibodies against NRF1 (A5547, 1:2000 dilution, ABclonal), LPCAT1 (A4987,1:2000 dilution, ABclonal), β-actin (66,009–1- Ig, 1:5000 dilution, Proteintech), Cyclin D1 (ab40754, 1:1000 dilution, Abcam), CDK4 (ab7955, 1:1000 dilution, Abcam), Cyclin E1 (ab71535, 1:2000 dilution, Abcam), CDK2 (ab32147, 1:1000 dilution, Abcam), E-cadherin (3195, 1:1000 dilution, Cell Signaling Technology), N-cadherin (13,116, 1:1000 dilution Cell Signaling Technology), Vimentin (5741, 1:1000 dilution, Cell Signaling Technology), p-ERK1/2 (Thr202/Tyr204) (4370, 1:1000 dilution, Cell Signaling Technology), ERK1/2 (4695, 1:1000 dilution, Cell Signaling Technology), p-CREB (Ser133) (9198, 1:1000 dilution, Cell Signaling Technology), CREB (9197, 1:1000 dilution, Cell Signaling Technology), PCNA(13,110, 1:1000 dilution, Cell Signaling Technology).

Techniques: Activity Assay, Expressing, Western Blot, Quantitative RT-PCR

Fig. 3 NRF1 facilitates migration and invasion of HCC cells by regulating epithelial-mesenchymal transition. A-B Huh7 and MHCC97 cell migration (A) and invasion (B) ability were analysed by transwell assay after NRF1 knockdown or overexpression. Scale bar: 100 μm. The bar graph showed the relative cell number. C Huh7 and MHCC97H cell migration ability was analysed by wound healing assay after NRF1 knockdown or overexpression. Scale bar: 100 μm. The bar graphs showed the quantitative wound healing ability. D GSEA using EMT gene set between high NRF1 and low NRF1 group in TCGA-LIHC dataset. E Western blot showed the EMT related protein levels in Huh7 and MHCC97H after NRF1 knockdown or overexpression. *p < 0.05, ** p < 0.01, *** p < 0.001

Journal: Biology direct

Article Title: Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1/2-CREB axis.

doi: 10.1186/s13062-023-00428-z

Figure Lengend Snippet: Fig. 3 NRF1 facilitates migration and invasion of HCC cells by regulating epithelial-mesenchymal transition. A-B Huh7 and MHCC97 cell migration (A) and invasion (B) ability were analysed by transwell assay after NRF1 knockdown or overexpression. Scale bar: 100 μm. The bar graph showed the relative cell number. C Huh7 and MHCC97H cell migration ability was analysed by wound healing assay after NRF1 knockdown or overexpression. Scale bar: 100 μm. The bar graphs showed the quantitative wound healing ability. D GSEA using EMT gene set between high NRF1 and low NRF1 group in TCGA-LIHC dataset. E Western blot showed the EMT related protein levels in Huh7 and MHCC97H after NRF1 knockdown or overexpression. *p < 0.05, ** p < 0.01, *** p < 0.001

Article Snippet: After being blocked by skim milk, PVDF membranes were incubated with corresponding primary antibodies against NRF1 (A5547, 1:2000 dilution, ABclonal), LPCAT1 (A4987,1:2000 dilution, ABclonal), β-actin (66,009–1- Ig, 1:5000 dilution, Proteintech), Cyclin D1 (ab40754, 1:1000 dilution, Abcam), CDK4 (ab7955, 1:1000 dilution, Abcam), Cyclin E1 (ab71535, 1:2000 dilution, Abcam), CDK2 (ab32147, 1:1000 dilution, Abcam), E-cadherin (3195, 1:1000 dilution, Cell Signaling Technology), N-cadherin (13,116, 1:1000 dilution Cell Signaling Technology), Vimentin (5741, 1:1000 dilution, Cell Signaling Technology), p-ERK1/2 (Thr202/Tyr204) (4370, 1:1000 dilution, Cell Signaling Technology), ERK1/2 (4695, 1:1000 dilution, Cell Signaling Technology), p-CREB (Ser133) (9198, 1:1000 dilution, Cell Signaling Technology), CREB (9197, 1:1000 dilution, Cell Signaling Technology), PCNA(13,110, 1:1000 dilution, Cell Signaling Technology).

Techniques: Migration, Transwell Assay, Knockdown, Over Expression, Wound Healing Assay, Western Blot

Fig. 7 NRF1 promotes HCC growth in vivo. Lentivirus was used to establish stable NRF1 knockdown Huh7 cell lines and tumor growth ability was assessed with subcutaneous xenograft model. A The image of subcutaneous xenograft tumors were shown. B The tumor volume was measured every three days. C The mass of the subcutaneous xenograft tumors was weighed after excision. D Representative images of IHC staining and the IHC scores of NRF1, LPCAT1, p-ERK1/2, p-CREB, Ki67 and Vimentin of the tumors. Scale bar: 50 μm. E NRF1, LPCAT1, p-ERK1/2, ERK1/2, p-CREB, CREB, PCNA and Vimentin were analyzed with Western blot. Bar graphs showed the quantitative results. *p < 0.05, **p < 0.01, ***p < 0.001

Journal: Biology direct

Article Title: Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1/2-CREB axis.

doi: 10.1186/s13062-023-00428-z

Figure Lengend Snippet: Fig. 7 NRF1 promotes HCC growth in vivo. Lentivirus was used to establish stable NRF1 knockdown Huh7 cell lines and tumor growth ability was assessed with subcutaneous xenograft model. A The image of subcutaneous xenograft tumors were shown. B The tumor volume was measured every three days. C The mass of the subcutaneous xenograft tumors was weighed after excision. D Representative images of IHC staining and the IHC scores of NRF1, LPCAT1, p-ERK1/2, p-CREB, Ki67 and Vimentin of the tumors. Scale bar: 50 μm. E NRF1, LPCAT1, p-ERK1/2, ERK1/2, p-CREB, CREB, PCNA and Vimentin were analyzed with Western blot. Bar graphs showed the quantitative results. *p < 0.05, **p < 0.01, ***p < 0.001

Article Snippet: After being blocked by skim milk, PVDF membranes were incubated with corresponding primary antibodies against NRF1 (A5547, 1:2000 dilution, ABclonal), LPCAT1 (A4987,1:2000 dilution, ABclonal), β-actin (66,009–1- Ig, 1:5000 dilution, Proteintech), Cyclin D1 (ab40754, 1:1000 dilution, Abcam), CDK4 (ab7955, 1:1000 dilution, Abcam), Cyclin E1 (ab71535, 1:2000 dilution, Abcam), CDK2 (ab32147, 1:1000 dilution, Abcam), E-cadherin (3195, 1:1000 dilution, Cell Signaling Technology), N-cadherin (13,116, 1:1000 dilution Cell Signaling Technology), Vimentin (5741, 1:1000 dilution, Cell Signaling Technology), p-ERK1/2 (Thr202/Tyr204) (4370, 1:1000 dilution, Cell Signaling Technology), ERK1/2 (4695, 1:1000 dilution, Cell Signaling Technology), p-CREB (Ser133) (9198, 1:1000 dilution, Cell Signaling Technology), CREB (9197, 1:1000 dilution, Cell Signaling Technology), PCNA(13,110, 1:1000 dilution, Cell Signaling Technology).

Techniques: In Vivo, Knockdown, Immunohistochemistry, Western Blot

Fig. 8 NRF1 promotes HCC metastasis in vivo. Lentivirus was used to establish stable NRF1 knockdown MHCC97H cell lines and tumor metastasis ability was assessed with tail vein injection model. A Lungs of the nude mice were excised and photographed. Arrows indicate metastasis loci. B Representative images of HE staining of the lungs to evaluate metastasis nodes. Arrows indicate metastasis loci. Scale bars: 1 mm. C The number of quantitative results of lung metastasis tumor. D The schematic of the present study. *p < 0.05, **p < 0.01, ***p < 0.001

Journal: Biology direct

Article Title: Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1/2-CREB axis.

doi: 10.1186/s13062-023-00428-z

Figure Lengend Snippet: Fig. 8 NRF1 promotes HCC metastasis in vivo. Lentivirus was used to establish stable NRF1 knockdown MHCC97H cell lines and tumor metastasis ability was assessed with tail vein injection model. A Lungs of the nude mice were excised and photographed. Arrows indicate metastasis loci. B Representative images of HE staining of the lungs to evaluate metastasis nodes. Arrows indicate metastasis loci. Scale bars: 1 mm. C The number of quantitative results of lung metastasis tumor. D The schematic of the present study. *p < 0.05, **p < 0.01, ***p < 0.001

Article Snippet: After being blocked by skim milk, PVDF membranes were incubated with corresponding primary antibodies against NRF1 (A5547, 1:2000 dilution, ABclonal), LPCAT1 (A4987,1:2000 dilution, ABclonal), β-actin (66,009–1- Ig, 1:5000 dilution, Proteintech), Cyclin D1 (ab40754, 1:1000 dilution, Abcam), CDK4 (ab7955, 1:1000 dilution, Abcam), Cyclin E1 (ab71535, 1:2000 dilution, Abcam), CDK2 (ab32147, 1:1000 dilution, Abcam), E-cadherin (3195, 1:1000 dilution, Cell Signaling Technology), N-cadherin (13,116, 1:1000 dilution Cell Signaling Technology), Vimentin (5741, 1:1000 dilution, Cell Signaling Technology), p-ERK1/2 (Thr202/Tyr204) (4370, 1:1000 dilution, Cell Signaling Technology), ERK1/2 (4695, 1:1000 dilution, Cell Signaling Technology), p-CREB (Ser133) (9198, 1:1000 dilution, Cell Signaling Technology), CREB (9197, 1:1000 dilution, Cell Signaling Technology), PCNA(13,110, 1:1000 dilution, Cell Signaling Technology).

Techniques: In Vivo, Knockdown, Injection, Staining